Topline results from the ATTAIN-MAINTAIN trial show that orforglipron, an investigational oral GLP-1 RA, helps people maintain weight loss after switching from an injectable.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/orforglipron-helps-maintain-weight-loss-after-injectables-2025a1000zq2?src=rss
Author :
Publish date : 2025-12-18 17:37:00
Copyright for syndicated content belongs to the linked Source.